Evidence map›Paper›PMID 36615008›Full record

ArticleJournal of clinical medicine2022

The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington's Disease from China: A Cross-Sectional Study.

Yangfan Cheng, Xiaojing Gu, Kuncheng Liu, Tianmi Yang, Yi Xiao, Qirui Jiang, Jingxuan Huang, Junyu Lin, Qianqian Wei, Ruwei Ou and 5 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The pathobiology of depression in Huntington's disease: an unresolved puzzle.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yangfan ChengDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Xiaojing GuDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Kuncheng LiuDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Tianmi YangDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Yi XiaoDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Qirui JiangDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Jingxuan HuangDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Junyu LinDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Qianqian WeiDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Ruwei OuDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Yanbing HouDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Lingyu ZhangDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Chunyu LiDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Jean-Marc BurgunderDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Huifang ShangDepartment of Neurology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0000-0003-0947-1151

Funding

Sichuan province Science and Technology Program 2022ZDZX0023
6 · The paper itself

Abstract

Huntington’s disease (HD) is an autosomal dominant inherited neurodegenerative disorder caused by CAG repeats expansion. There is a paucity of comprehensive clinical analysis in Chinese HD patients due to the low prevalence of HD in Asia. We aimed to comprehensively describe the motor, neuropsychiatric symptoms, and functional assessment in patients with HD from China. A total of 205 HD patients were assessed by the Unified Huntington’s Disease Rating Scale (UHDRS), the short version of Problem-Behavior Assessment (PBA-s), Hamilton Depression Scale (HAMD) and Beck Depression Inventory (BDI). Multivariate logistic regression analysis was used to explore the independent variables correlated with neuropsychiatric subscales. The mean age of motor symptom onset was 41.8 ± 10.0 years old with a diagnostic delay of 4.3 ± 3.8 years and a median CAG repeats of 44. The patients with a positive family history had a younger onset and larger CAG expansion than the patients without a family history (p < 0.05). There was a significant increase in total motor score across disease stages (p < 0.0001). Depression (51%) was the most common neuropsychiatric symptom at all stages, whereas moderate to severe apathy commonly occurred in advanced HD stages. We found lower functional capacity and higher HAMD were independently correlated with irritability; higher HAMD and higher BDI were independently correlated with affect; male sex and higher HAMD were independently correlated with apathy. In summary, comprehensive clinical profile analysis of Chinese HD patients showed not only chorea-like movement, but psychiatric symptoms were outstanding problems and need to be detected early. Our study provides the basis to guide clinical practice, especially in practical diagnostic and management processes.

Indexed as

Chinese populationHuntington’s diseasemotor assessmentneuropsychiatric symptoms

Identifiers

PMID36615008
PMCPMC9821667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.